| Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and … T André, A De Gramont, D Vernerey, B Chibaudel, F Bonnetain, ... Journal of Clinical Oncology 33 (35), 4176-4187, 2015 | 697 | 2015 |
| Expression of somatostatin receptor types 1–5 in 81 cases of gastrointestinal and pancreatic endocrine tumors: a correlative immunohistochemical and reverse-transcriptase … M Papotti, M Bongiovanni, M Volante, E Allia, S Landolfi, L Helboe, ... Virchows Archiv 440, 461-475, 2002 | 636 | 2002 |
| Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity M Scaltriti, C Verma, M Guzman, J Jimenez, JL Parra, K Pedersen, ... Oncogene 28 (6), 803-814, 2009 | 491 | 2009 |
| β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer SP Tenbaum, P Ordóñez-Morán, I Puig, I Chicote, O Arqués, S Landolfi, ... Nature medicine 18 (6), 892-901, 2012 | 418 | 2012 |
| Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients M Volante, S Landolfi, L Chiusa, N Palestini, M Motta, A Codegone, ... Cancer 100 (5), 950-957, 2004 | 260 | 2004 |
| Level of HER2 Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab C Gomez-Martin, JC Plaza, R Pazo-Cid, A Salud, F Pons, P Fonseca, ... Journal of Clinical Oncology 31 (35), 4445-4452, 2013 | 207 | 2013 |
| p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas M Santos, S Landolfi, A Olivella, B Lloveras, J Klaustermeier, H Suárez, ... The American journal of surgical pathology 30 (11), 1347-1356, 2006 | 182 | 2006 |
| Tankyrase inhibition blocks Wnt/β-catenin pathway and reverts resistance to PI3K and AKT inhibitors in the treatment of colorectal cancer O Arqués, I Chicote, I Puig, SP Tenbaum, G Argilés, R Dienstmann, ... Clinical cancer research 22 (3), 644-656, 2016 | 166 | 2016 |
| RHOA inactivation enhances Wnt signalling and promotes colorectal cancer P Rodrigues, I Macaya, S Bazzocco, R Mazzolini, E Andretta, H Dopeso, ... Nature communications 5 (1), 5458, 2014 | 111 | 2014 |
| Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials R Dienstmann, D Serpico, J Rodon, C Saura, T Macarulla, E Elez, ... Molecular cancer therapeutics 11 (9), 2062-2071, 2012 | 97 | 2012 |
| A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells I Puig, I Chicote, SP Tenbaum, O Arqués, JR Herance, JD Gispert, ... Clinical Cancer Research 19 (24), 6787-6801, 2013 | 94 | 2013 |
| p16INK4a immunostaining identifies occult CIN lesions in HPV-positive women J Ordi, S Garcia, M del Pino, S Landolfi, I Alonso, L Quintó, A Torné International journal of gynecological pathology 28 (1), 90-97, 2009 | 90 | 2009 |
| The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis H Dopeso, S Mateo-Lozano, R Mazzolini, P Rodrigues, L Lagares-Tena, ... Cancer research 69 (18), 7430-7438, 2009 | 86 | 2009 |
| DPYD genotyping to predict adverse events following treatment with fluorouracil-based adjuvant chemotherapy in patients with stage III colon cancer: a secondary analysis of the … V Boige, M Vincent, P Alexandre, S Tejpar, S Landolfi, K Le Malicot, ... JAMA oncology 2 (5), 655-662, 2016 | 80 | 2016 |
| SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity A Barbáchano, P Ordóñez-Morán, JM García, A Sánchez, F Pereira, ... Oncogene 29 (34), 4800-4813, 2010 | 77 | 2010 |
| Brush border myosin Ia has tumor suppressor activity in the intestine R Mazzolini, H Dopeso, S Mateo-Lozano, W Chang, P Rodrigues, ... Proceedings of the National Academy of Sciences 109 (5), 1530-1535, 2012 | 72 | 2012 |
| Myo5b knockout mice as a model of microvillus inclusion disease F Cartón-García, AW Overeem, R Nieto, S Bazzocco, H Dopeso, I Macaya, ... Scientific reports 5 (1), 1-10, 2015 | 68 | 2015 |
| Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma F Lesueur, M Corbex, JD McKay, J Lima, P Soares, P Griseri, J Burgess, ... Journal of medical genetics 39 (4), 260-265, 2002 | 66 | 2002 |
| Risk of progression to high-grade anal intraepithelial neoplasia in HIV-infected MSM J Burgos, A Curran, N Tallada, A Guelar, J Navarro, S Landolfi, J Villar, ... Aids 29 (6), 695-702, 2015 | 64 | 2015 |
| Risk factors for positive findings in patients with high‐grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette‐Guérin … A Orsola, L Cecchini, CX Raventós, E Trilla, J Planas, S Landolfi, ... BJU international 105 (2), 202-207, 2010 | 49 | 2010 |
